Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne C Goldberg

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
American Heart Journal|November 7, 2015
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAnn Marie Navar, Tracy Y Wang, Anne C Goldberg, et al.
American Heart Journal|November 14, 2017
Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) RegistryAnn Marie Navar, Tracy Y Wang, Shuang Li, et al.
Journal of the American Heart Association|May 10, 2018
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) RegistryMichael G Nanna, Ann Marie Navar, Tracy Y Wang, et al.
Journal of the American Heart Association|March 28, 2019
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM RegistryCorey K Bradley, Tracy Y Wang, Shuang Li, et al.
American Heart Journal|June 3, 2020
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registryAngela Lowenstern, Shuang Li, Salim S Virani, et al.
Circulation. Cardiovascular Quality and Outcomes|March 17, 2018
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) RegistryAnn Marie Navar, Eric D Peterson, Shuang Li, et al.
Journal of the American Heart Association|October 30, 2018
Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM RegistryAngela M Lowenstern, Shuang Li, Ann Marie Navar, et al.
JAMA Cardiology|June 14, 2018
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management RegistryMichael G Nanna, Ann Marie Navar, Pearl Zakroysky, et al.
American Heart Journal|June 16, 2019
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registryMichael G Nanna, Ann Marie Navar, Tracy Y Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|August 17, 2019
Sex Differences in the Use of Statins in Community PracticeMichael G Nanna, Tracy Y Wang, Qun Xiang, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
American Heart Journal|November 7, 2015
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAnn Marie Navar, Tracy Y Wang, Anne C Goldberg, et al.
American Heart Journal|November 14, 2017
Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) RegistryAnn Marie Navar, Tracy Y Wang, Shuang Li, et al.
Journal of the American Heart Association|May 10, 2018
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) RegistryMichael G Nanna, Ann Marie Navar, Tracy Y Wang, et al.
Journal of the American Heart Association|March 28, 2019
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM RegistryCorey K Bradley, Tracy Y Wang, Shuang Li, et al.
American Heart Journal|June 3, 2020
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registryAngela Lowenstern, Shuang Li, Salim S Virani, et al.
Circulation. Cardiovascular Quality and Outcomes|March 17, 2018
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) RegistryAnn Marie Navar, Eric D Peterson, Shuang Li, et al.
Journal of the American Heart Association|October 30, 2018
Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM RegistryAngela M Lowenstern, Shuang Li, Ann Marie Navar, et al.
JAMA Cardiology|June 14, 2018
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management RegistryMichael G Nanna, Ann Marie Navar, Pearl Zakroysky, et al.
American Heart Journal|June 16, 2019
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registryMichael G Nanna, Ann Marie Navar, Tracy Y Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|August 17, 2019
Sex Differences in the Use of Statins in Community PracticeMichael G Nanna, Tracy Y Wang, Qun Xiang, et al.
Pageof 7